[Prognosis and survival of esophageal cancer in Cameroon: a prognostic study].

Clicks: 217
ID: 18180
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #52 of 76 articles by views in The Pan African medical journal

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Esophageal cancer is rare. Poor prognosis is due to delayed diagnosis. Five year survival is less than 20%. This study aimed to investigate the factors associated with survival of patients with esophageal cancer in Cameroon.We conducted a prognostic study in the General Hospitals in Yaoundé and in Douala over a period of 11 years from 1 January 2005 to 31 December 2015. The parameters studied were those associated with survival. Survival was established on the basis of the date of diagnosis and of the date of death or of the last visit. SPSS software (Statistical Package for Social Sciences) version 23 allowed for data analysis. Kaplan Meier curve was used to estimate the survival function. Log RankTest allowed for comparison among the different groups. Cox regression helped to highlight the different factors associated with it. Significance level was set at 0.05.We collected data from 49 medical records. The average age of patients was 57.83 years. There was a male predominance (71.4%; n=35) with a sex ratio of 2.49. The follow-up period was 3.2 months. Median survival was 6.67 months (CI 95% [1.33-10.4]) and the average survival time was 7.99 months (CI 95% [4.42-11.17]). Multivariate-adjusted analysis showed that stage IV was a predictive factor of mortality (HR = 2.79; CI95% [1.13-6.89], p = 0.025]).Esophageal cancer is a rare disease with poor prognosis. Prognostic factor is the tumor stage.
Reference Key
nga2019prognosisthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Nga, Winnie Tatiana Bekolo;Eloumou, Servais Albert Fiacre Bagnaka;Engbang, Jean Paul Ndamba;Bell, Esther Mbassi Dina;Mayeh, Anne Marthe Maison;Atenguena, Etienne;Biwole, Martin Essomba;Ayissi, Georges Barthélémy Nko'o;Kenfack, Gabin;Noah, Dominique Noah;Luma, Henry Namme;Sone, Albert Mouelle;Ndom, Paul;Ndam, Elie Claude Ndjitoyap;
Journal The Pan African medical journal
Year 2019
DOI
10.11604/pamj.2019.33.73.16112
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.